Literature DB >> 10885905

Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.

X W Zhang1, C Qing, B Xu.   

Abstract

10-Hydroxycamptothecin (HCPT), a DNA topoisomerase I inhibitor, is an antitumor alkaloid isolated from a Chinese tree, Camptotheca acuminata, and exhibits a remarkable antihepatoma effect. We studied HCPT to determine whether or not its anti-hepatoma activity occurs through apoptosis induction and cell cycle disturbance using the MTT method, DAPI staining, agarose gel electrophoresis and flow cytometric analysis. The results showed that HCPT inhibited proliferation of human hepatoma Hep G2, Bel-7402 and Bel-7404 cells at an optimal concentration of 0.1 microg/ml. This growth inhibition was dose and time dependent, and was accompanied by evidence of apoptotic changes and cell cycle perturbation in Hep G2 cells. Chromatin condensation and nuclear fragmentation were observed in Hep G2 cells by fluorescence microscopy. Agarose gel electrophoresis showed internucleosomal DNA fragmentation ('ladder pattern') of Hep G2 cells following treatment with HCPT, in a concentration- and time-dependent manner. Flow cytometry showed that HCPT induced a massive hypodiploid cell population and arrested cells in G2/M phase (at low dose) or in S phase (at high dose) in Hep G2 cells. The results of this study suggest that the anti-hepatoma effect of HCPT may result from apoptosis induction and cell cycle disturbance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10885905     DOI: 10.1097/00001813-199907000-00009

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  7 in total

1.  Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.

Authors:  Zhi-Jian Yu; Jia-Wei Yu; Wei Cai; Hong-Xin Yuan; Xiao-Yan Li; Ye Yuan; Jian-Ping Chen; Xiao-Yin Wu; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

2.  Development of purely structure-based pharmacophores for the topoisomerase I-DNA-ligand binding pocket.

Authors:  Malgorzata N Drwal; Keli Agama; Yves Pommier; Renate Griffith
Journal:  J Comput Aided Mol Des       Date:  2013-12-01       Impact factor: 3.686

3.  Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.

Authors:  Peng-Cheng Li; Liang-Dong Chen; Fang Zheng; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-31       Impact factor: 4.553

4.  Exploring DNA topoisomerase I ligand space in search of novel anticancer agents.

Authors:  Malgorzata N Drwal; Keli Agama; Laurence P G Wakelin; Yves Pommier; Renate Griffith
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

5.  Inhibition of Breast Tumor Cell Growth by Ectopic Expression of p16/INK4A Via Combined Effects of Cell Cycle Arrest, Senescence and Apoptotic Induction, and Angiogenesis Inhibition.

Authors:  Yi Lu; Xiongwen Zhang; Jun Zhang
Journal:  J Cancer       Date:  2012-08-01       Impact factor: 4.207

6.  Antitumor Effects and Biological Mechanism of Action of the Aqueous Extract of the Camptotheca acuminata Fruit in Human Endometrial Carcinoma Cells.

Authors:  Chi-Shian Lin; Pin-Chien Chen; Chien-Kai Wang; Chia-Woei Wang; Yu-Jia Chang; Cheng-Jeng Tai; Chen-Jei Tai
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-21       Impact factor: 2.629

7.  Astragalus polysaccharide combined with 10-hydroxycamptothecin inhibits metastasis in non-small cell lung carcinoma cell lines via the MAP4K3/mTOR signaling pathway.

Authors:  Yang Zhou; Tao Hong; Li Tong; Wei Liu; Xueting Yang; Jianghan Luo; Fuling Wang; Jian Li; Lijun Yan
Journal:  Int J Mol Med       Date:  2018-09-07       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.